The variation operating system
Every change routed to the right procedure — built for Art. 92.
Change #8 of 10 — RA Operations
Minor changes no longer need a variation. They need a database update.
Article 92 overhauls the variation framework: fully electronic submission, database record updates for truly minor changes, enhanced grouped variations, and formalised PACMPs for connected change programmes. Your variation operating model is changing — not just the forms.
Art. 92 — Variations
Fully electronicMinor changes leave the variation system
Example: a company address change
Today
Type IA variation
Filing fee30-day clockDossier
New directive
Database update
No feeNo clockInstant
Bigger changes still scale up:Type IBType IIPACMP
Routine admin changes no longer consume a variation procedure — they become instant database updates, and the whole framework moves fully electronic.
The operational impact
Faster for some changes. Completely different for others.
Database updates eliminate procedures that previously required Type IA filings. PACMPs transform connected change programmes. Electronic-only affects every procedure simultaneously.
100%
Of variation procedures become electronic-only from mid-2028 — CAPs and NAPs
SourceArt. 92, EU Pharmaceutical Directive 2026
0days
Assessment time for changes eligible for database record update vs 30-day Type IA
SourceArt. 92, EU Pharmaceutical Directive 2026
~40%
Of typical RA variation workload is Type IA and administrative — most directly simplified
SourceEMA variation workload analysis, 2023
What's actually changing
From paper procedure to electronic operating model
Five parallel shifts happening simultaneously — each affects a different part of your variation operations.
Workbench
+ New TaskQuick Tasks/Variations — current vs new directive
We submit around 300 Type IA variations a year. Most look like they're address changes or minor document updates. Do we still need to file them?
RegIntel12:39
126.00s256 sources95% confidence2 warnings
2 warnings
Here's the obligation delta for Variations. The new EU Pharmaceutical Directive replaces Directive 2001/83/EC[1][2] — below is what changes, row by row.
Current vs. new directive4 rows
Change area
Current — 2001/83/EC
New directive — from ~mid-2028
Submission format
Current
Mix of electronic and paper. Type IA often via email with PDF attachments. Paper persists in many national procedures.
Minor administrative changes
Current
Administrative changes require formal Type IA notification — company name, address, contact details. Each change is a separate procedure with filing fee.
New directive
Purely administrative changes handled as database record updates — no assessment clock, no dossier, no filing fee. Immediate registry amendment.[5]
Grouped variations
Current
Grouping rules complex. Type II changes slow down all IA/IB components in the same group.
New directive
Enhanced grouping with clearer rules. Annual Type IA notification batches multiple changes in a rolling 12-month period.[6]
⚠Dates reflect the political agreement text; final deadlines depend on entry into force and the transition period for each obligation.
Synthesised from 24 citations across 256 regulatory sources.
Book a 15-minute live walkthrough of the Workbench
Where teams get stuck
The missing layer
Benefits only materialise if your team knows which procedure applies and can use the new pathways from day one.
CU
Current variation SOPs
The existing playbook
EL
Electronic submission tools
The submission portals
How Regunaut solves it
Five steps. Your variation operations on the new framework.
Each step maps variation management under Art. 92 — from classifying changes through PACMP-based programmes.
Questionnaire-based classification engine routes changes to DB update, IA, IB, II, or PACMP based on EMA taxonomy, authorisation route, and active PACMPs in your portfolio.
- Art. 92 aligned classification: DB update / IA / IB / II / PACMP
- CAP vs NAP aware classification logic
- PACMP overlap check on active protocols
- Classification rationale documentation for audits
Operational evidence
Variation volume is growing. The new framework needs to handle it efficiently.
EMA's electronic-only mandate and new pathway options reduce overhead — but only for teams equipped to use them correctly.
18k+
Variation procedures assessed by EMA annually for CAPs alone — national procedures add multiples
EMA Annual Report, 2023
30%
Reduction in Type IA processing time in EMA's electronic-only pilot for CAP variations
EMA e-submission pilot evaluation, 2023
12mo
Typical time for a complex manufacturing change programme across 10+ MAs — the scenario PACMPs compress
EFPIA variation operations survey, 2024
“Variations are the daily engine of regulatory operations. Teams that rebuild around Art. 92 will move faster. Teams that adapt incrementally will carry the overhead of a framework that no longer exists.”
Common questions
What RA teams are asking about the variation reform
Rebuild your variation operating model before mid-2028
Your SOPs, tracking tools and submission workflows are built for a framework being replaced.
Audit your variation operations
Map your portfolio against Art. 92 classification — which procedures change type, which become database updates.
Streamline my variationsDesign a PACMP for your portfolio
30-minute session to identify change programmes best suited for PACMP treatment.
Book a PACMP scoping session